Comparative Risks of High-Grade Adverse Events Among FDA-Approved Systemic Therapies in Advanced Melanoma: Systematic Review and Network Meta-Analysis

Background: Head-to-head evidence is lacking in comparative risks of high-grade adverse events (AEs) among different systemic treatment options for advanced melanoma. Methods: An up-to-date systematic review and network meta-analysis (NMA) was performed. Randomized controlled trials (RCTs) of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ya-fang, Xie, Wen-jie, Fan, Hai-yu, Du, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593404/
https://www.ncbi.nlm.nih.gov/pubmed/33178599
http://dx.doi.org/10.3389/fonc.2020.571135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593404/
https://www.ncbi.nlm.nih.gov/pubmed/33178599
http://dx.doi.org/10.3389/fonc.2020.571135

Ejemplares similares